Incidence of acute kidney injury in patients with relapsed and refractory multiple myeloma treated with teclistamab vs chimeric antigen receptor T-cell therapy

被引：0
|
作者：
Charkviani, Mariam
Vaughan, Lisa E.
Sandahl, Tyler B.
Lin, Yi
Leung, Nelson
Herrmann, Sandra M.
机构：
[1] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN USA
[4] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7542
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy
    Jagannath, Sundar
    Kharat, Akshay
    Fu, Alex
    Huo, Stephen
    Kohli, Monal
    Adams, Shayna
    Umeh, Emeka
    Foster, Miran
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S511 - S512
  • [32] Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma
    Zu, Cheng
    Xu, Yufeng
    Wang, Yiyun
    Zhang, Mingming
    Zhao, Houli
    Fang, Xiaoyun
    Huang, He
    Hu, Yongxian
    CURRENT ONCOLOGY, 2022, 29 (02) : 490 - 496
  • [33] Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies
    Leon-Roman, Juan
    Iacoboni, Gloria
    Bermejo, Sheila
    Carpio, Cecilia
    Bolufer, Monica
    Garcia-Carro, Clara
    Sanchez-Salinas, Mario
    Alonso-Martinez, Carla
    Bestard, Oriol
    Barba, Pere
    Soler, Maria Jose
    CLINICAL KIDNEY JOURNAL, 2024, 17 (03)
  • [34] Incidence and Risk Factors Associated With Bleeding Following Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
    Mohammed, Turab
    Peres, Lauren
    Colinleitzinger, Christelle
    Puglianini, Omar Castaneda
    Oswald, Laura
    De Avila, Gabe
    Grajales-Cruz, Ariel
    Blue, Brandon
    Ochoa-Bayona, Jose
    Khimani, Farhad
    Faramand, Rawan
    Elmariah, Hany
    Lazaryan, Aleksandr
    Jain, Michael
    Liu, Hein
    Nishihori, Taiga
    Shain, Ken
    Baz, Rachid
    Alsina, Melissa
    Locke, Frederick
    Freeman, Ciara
    Hansen, Doris
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S473 - S474
  • [35] A successful haploidentical transplantation without conditioning regimen for a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T-cell therapy
    Dai, Zigang
    Yu, Nanzhou
    Cao, Yang
    Zhou, Jianfeng
    Zhang, Yicheng
    Wang, Na
    Zhou, Xiaoxi
    CYTOTHERAPY, 2025, 27 (03) : 295 - 299
  • [36] Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma
    Giri, Smith
    Bal, Susan
    Godby, Kelly N.
    Ravi, Gayathri
    Clark, Deanna
    Ubersax, Clare
    Cooley, Abigail
    White, Priscila
    Rangarajan, Sunil
    Williams, Grant R.
    Costa, Luciano J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : E153 - E155
  • [37] Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
    Ma, Sha
    Li, Hujun
    Zhou, Dian
    Zhang, Xiaotian
    Shi, Ming
    Cao, Jiang
    Qi, Yuekun
    Xia, Jieyun
    Liu, Yang
    Wang, Xue
    Li, Depeng
    Sang, Wei
    Yan, Zhiling
    Zhu, Feng
    Sun, Haiying
    Cheng, Hai
    Zheng, Junnian
    Xu, Kailin
    Li, Zhenyu
    Qi, Kunmin
    Wang, Ying
    CYTOTHERAPY, 2023, 25 (06) : 653 - 658
  • [38] Chimeric antigen receptor T-cell therapies for multiple myeloma
    Mikkilineni, Lekha
    Kochenderfer, James N.
    BLOOD, 2017, 130 (24) : 2594 - 2602
  • [39] An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis
    Pereira, Rita
    Bergantim, Rui
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [40] Chimeric antigen receptor T cell therapy for multiple myeloma
    Kana Hasegawa
    Naoki Hosen
    Inflammation and Regeneration, 39
12345